The rating upgrade was supported by a number of factors, including Rady’s 88 percent market share in its primary service area, strong profitability and clinical affiliation with the University of California, San Diego.
Rady’s growing liquidity also supported the rating upgrade. Rady’s total unrestricted cash and investments was $777 million as of June 30, up from $617.9 million the prior year.
Fitch Ratings also revised Rady Children’s outlook to stable from positive.
More articles on healthcare finance:
Can we control healthcare costs without price caps?
Moody’s assigns ‘A3’ rating to Central Florida Health Alliance’s bonds
Moody’s revises Methodist Le Bonheaur Healthcare’s outlook to stable
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
